HIV/AIDS in the Middle East and North Africa : the costs of inaction /

This work shows that although most evidence suggests HIV prevalence is low in the Middle East and North Africa region, greater investments in improved surveillance, prevention, and care are needed - to maintain low prevalence levels and preserve the focus on national and regional development goals.

Bibliographic Details
Call Number:Libro Electrónico
Main Author: Jenkins, Carol Lynn
Corporate Authors: World Bank, World Health Organization. Regional Office for the Eastern Mediterranean, Joint United Nations Programme on HIV/AIDS
Other Authors: Robalino, David A.
Format: Electronic eBook
Language:Inglés
Published: Washington, DC : World Bank, ©2003.
Series:Orientations in development.
Subjects:
HIV infections > Africa, North.
HIV infections > Middle East.
AIDS (Disease) > Africa, North.
HIV infections.
AIDS (Disease)
AIDS (Disease) > Middle East.
HIV Infections
Acquired Immunodeficiency Syndrome
Infections à VIH > Afrique du Nord.
Infections à VIH > Moyen-Orient.
Sida > Afrique du Nord.
Sida > Moyen-Orient.
Infections à VIH.
Sida.
MEDICAL > AIDS & HIV.
HEALTH & FITNESS > Diseases > AIDS & HIV.
HIV infections
Prävention
Aids
Africa, North.
Middle East.
Africa, Northern
Middle East
Afrique du Nord.
Moyen-Orient.
North Africa
Naher Osten
Nordafrika
Andre fag (naturvidenskab og teknik) > Andre fag
Online Access:Texto completo
Table of Contents:
  • Preface
  • Acronyms and Abbreviations
  • Executive Summary
  • Introduction
  • 1. Global Experience with HIV/AIDS
  • 2. Review of the HIV/AIDS Situation in the MENA/EM Region
  • 3. A Typology of Risk Factors
  • 4. Assessing the Potential Economic Impact of HIV/AIDS in the MENA/EM Region
  • 5. Responses to HIV/AIDS
  • 6. A Way Forward
  • Technical Appendix
  • References
  • Index
  • Boxes
  • Figures
  • Tables.

Similar Items